fda_483 · inspection_citation · high

NerPharMa S.r.l. -- FDA 483: 1 observation (2025-06-27)

Event date
2025-06-27 00:00:00Z
Observed
2026-07-12 22:32:05Z
Source ID
3004762406-2025-06-27-189639
Payload hash
8572b3e44269e75a7fa64bfe

Summary

Observation 1: Procedures designed to prevent microbiological contamination of diug products pmpo1ting to be sterile did not include adequate validation of the aseptic and sterilization process. Speci...

Informational only. Not legal, financial, or medical advice.